In patients with localized high-risk prostate cancer (T1-T3, PSA ≥20 ng/ml, Gleason score ≥7) suited for radiation therapy, staging lymphadenectomy is recommended by the German Society of Radiooncology (DEGRO; http://www.degro.org). The gene discussed is KLK3; the disease is Familial prostate cancer.